Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report

Thyroid

Volumn 7, Issue 3, 1997, Pages 433-439

  Mastorakos, George ^a   Mitsiades, Nicholas S ^a   Doufas, Anthony G ^a   Koutras, Demetrios A ^a,b  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LIOTHYRONINE; THYROXINE DEIODINASE;

ADOLESCENT; ADULT; ALBRIGHT SYNDROME; ARTICLE; CAFE AU LAIT SPOT; CHILD; DISEASE ASSOCIATION; ENZYME ACTIVATION; FEMALE; GENE MUTATION; GOITER; HORMONE RELEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROID DISEASE; THYROID FUNCTION;

EID: 0030739305     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.433     Document Type: Article

References (52)

1. McCune DJ, Bruch H 1937 Osteodystrophia fibrosa: report of a case in which condition was combined with precocious puberty, pathologic pigmentation of skin and hyperthyroidism, with a review of the literature. Am J Dis Child 54:806-848.
2. Albright F, Butler AM, Hampton AO, Smith P 1937 Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females. N Engl J Med 216:727-746.
3. Mastorakos G, Modigliani E, Hassan M, Gaudouen Y, Krivitzky A 1992 Acromegaly without pituitary adenoma in McCune-Albright syndrome, successfully treated with a somatostatin analog. J Pediatr Endocrinol 5:271-274.
4. Mauras N, Blizzard R 1986 The McCune-Albright syndrome. Acta Endocrinol (Copenh) 279(Suppl):207-217.
5. Weinstein LS, Shenker A 1993 G protein mutations in human disease. Clin Biochem 26:333-338.
6. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325:1688-1695.
7. Huang MJ, Li KL, Wei JS, Wu SS, Fan KD, Liaw YF 1994 Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study. Am J Gastroenterol 89:1071.
8. Gaupp V 1932 Pubertas praecox bei Osteodystrophia fibrosa. Monatschr f Kinderh 53:312.
9. Albright F, Scoville B, Sulkowitch HW 1938 Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and a gonadal dysfunction. Further observations including report of two more cases; discussion by R. Barnwell, patient of A. H. Musser. Endocrinology 22:411-421.
10. Summerfeldt P, Brown A 1939 Osteodystrophia fibrosa. Am J Dis Child 57:90.
11. Peck FB, Sage CV 1944 Diabetes mellitus associated with Albright's syndrome. Am J Med Sci 208:35.
12. Jervis GA, Schein H 1951 Polyostotic fibrous dysplasia (Albright's syndrome). Arch Pathol 51:640-650.
13. Yettra M, Starr P 1951 Polyostotic fibrous dysplasia associated with hyperthyroidism. J Clin Endocr 11:312-321.
14. Sternberg WH, Joseph V 1952 Osteodystrophia fibrosa combined with precocious puberty and exophthalmic goiter. Am J Dis Child 63:748-783.
15. Vague J, Marcorelles J, Coulomb J 1958 Dysplasie fibreuse des os, puberté précose, maigreur merveuse et hyperthyréose. Ann Endocrinol 19:1169-1173.
16. Halvorsen S, Aas K 1961 Renal tubular defects in fibrous dysplasia of the bones. Reports of two cases. Acta Pediatr 50:297.
17. Kim J P, Khera S AK 1961 Polyostotic fibrous dysplasia associated with hyperthyroidism. J Bone Joint Surg 43-A:897-904.
18. Benedict P 1962 Endocrine features in Albright's syndrome (fibrous dysplasia of bone). Metabolism 11:30-45.
19. Moldawer M, Rabin E R 1966 Polyostotic fibrous dysplasia with thyrotoxicosis. Arch Intern Med 118:379-384.
20. Zangeneh F, Lulejian GA, Steiner MM 1966 McCune-Albright syndrome with hyperthyroidism. Am J Dis Child 111:644-468.
21. Firat D, Stutzman L 1968 Fibrous dysplasia of the bone. Review of twenty-four cases. Am J Med 44:421-423.
22. Samuel S, Gilman S, Maurer HS, Rosenthal IM 1972 Hyperthyroidism in an infant with McCune-Albright syndrome: Report of a case with myeloid metaplasia. J Pediatr 80:275-278.
23. Hamilton CR Jr, Maloof F 1973 Unusual types of hyperthyroidism Medicine 52:195-215.
24. Andrews SB, Posen S 1974 Thyrotrophin in Albright's syndrome with hyperthyroidism [Letter to the Editor] Annals of Internal Medicine 81:561.
25. Tanaka T, Suwa S 1977 A case of McCune-Albright syndrome with hyperthyroidism and vitamin D-resistant rickets. Helv Pediatr Acta 32:263-273.
26. Giovanelli G, Bernasconi S, Banchini G 1978 McCune-Albright syndrome in a male child: a clinical and endocrinologic enigma. J Pediatr 92(Suppl 2):220-226.
27. Richton SM, Maclaren ML, McLaughlin JV, Raiti S 1979 Albright's syndrome presenting as thyrotoxicosis: Followup of a case. Pediatrics 63:159-162.
28. Albin J, Wu R 1981 Abnormal hypothalamic-pituitary function in polyostotic fibrous dysplasia. Clin Endocrinol (Oxf). 14:435-443.
29. D' Armiento M, Reda G, Camagna A, Tardella L 1983 McCune-Albright syndrome: evidence for autonomous multiendocrine hyperfunction. J Pediatr 102:584-586.
30. Domenech E, Santisteban M, Moya M, Gonzalez C, Cortabarria C, Mendez A, Alvarez J, Rodriguez-Luis JC 1985 [Transient neonatal hyperthyroidism in the child of a treated hyperthyroid mother. Subsequent appearance of sexual precocity] An Esp Pediatr 22:281-287.
31. Lee PA, Van Dop C, Migeon C 1986 McCune-Albright syndrome, long-term followup. JAMA 256(Suppl 1):2980-2984.
32. Misaki M, Shima T, Ikoma J, Morioka K, Suzuki S 1988 Acromegaly and hyperthyroidism associated with McCune-Albright syndrome. Horm Res 30:26-27.
33. Gallacher SJ, Wilson R, Boyle FT, Thompson JA 1989 The hyperthyroidism of polyostotic fibrous dysplasia - A possible autoimmune etiology. Scottish Med J 34:529.
34. Huang TS, Chang CC, Huang JS, Hsieh HC, Chen FW 1990 Albright's syndrome with acromegaly and Hashimoto's thyroiditis: report of a case. J Formosan Med Assoc 89:714-718.
35. Feuillan PP, Shawker T, Rose SR, Jones J, Jeevanram RK, Nisula B 1990 Thyroid abnormalities in the McCune-Albright syndrome: Ultrasonography and hormonal studies. J Clin Endocrinol Metab 71:1596-1601.
36. Abs R, Beckers A, Van de Vyver FL, De Schepper A, Stevenaert A, Hennen G 1990 Acromegaly, multinodular goiter and silent polyostotic fibrous dysplasia. A variant of the McCune-Albright syndrome. J Endocrinol Invest 13:671-675.
37. Yoshimoto M, Nakayama M, Baba T, Uehara T, Niikawa N, Ito M, Tsuji Y 1991 A case of neonatal McCune-Albright syndrome with Cushing syndrome and hyperthyroidism. Acta Paediatr Scand 80:984-987.
38. Lawless ST, Reeves G, Bowen JR 1992 The development of a thyroid storm in a child with McCune-Albright syndrome after orthopedic surgery. Am J Dis Child 146:1099-1102.
39. Schwindinger WF, Francomano CA, Levine MA 1992 Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 89:5152-5156.
40. Cavanah SF, Dons RF 1993 McCune-Albright syndrome: how many endocrinopathies can one patient have? South Med J 86:364-367.
41. Shenker A, Weinstein LS, Sweet DE, Spiegel AM 1994 An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab 79:750-755.
42. Boston BA, Mandel S, LaFranchi S, Bliziotes M 1994 Activating mutation in the stimulatory guanine nucleotide-binding protein in an infant with Cushing's syndrome and nodular adrenal hyperplasia. J Clin Endocrinol Metab 79:890-893.
43. Malchoff CD, Reardon G, MacGillivray DC, Yamase H, Rogol AD, Malchoff DM 1994 An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesion. J Clin Endocrinol Metab 78:803-806.
44. Roger PP, Taton M, Van Sande J, Dumont JE 1988 Mitogenic effects of thyrotropin and adenosine 3′-,5′-monophosphate in differentiated normal human thyroid cells in vitro. J Clin Endocrinol Metab 66:1158-1165.
45. sa stimulates growth and differentiation of thyroid FRTL5 cells. Oncogene 9:3647-3653.
46. Michiels FM, Caillou B, Talbot M, Dessarps-Freichey F, Maunoury MT, Schlumberger M, Mercken L, Monier R, Feunteun J. 1994 Oncogenic potential of guanine nucleotide stimulatory factor a subunit in thyroid glands of transgenic mice. Proc Nat Acad Sci USA 91:10488-10492.
47. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L 1989 GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340:692-696.
48. Lyons J, Landis CA, Harsh G, Vallar L, Grünewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR, McCormick F. 1990 Two G protein oncogenes in human endocrine tumors. Science 249:655-659.
49. O' Sullivan C, Barton CM, Staddon SL, Brown CL, Lemoine NR 1991 Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinogen 4:345-349.
50. Suarez HG, du Villard JA, Caillou B, Schlumberger M, Parmentier C, Monier R 1991 gsp mutations in human thyroid tumours. Oncogene 6:677-679.
51. Yoshimoto K, Iwahana H, Fukuda A, Sano T, Itakura M 1993 Rare mutations in the Gs alpha subunit gene in human endocrine tumors. Cancer 72:1386-1393.
52. Goretzki PE, Lyons J, Stacy-Phipps S, Rosenau W, Demeure M, Clark OH, McCormick F, Roher HD, Bourne HR 1992 Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implications. World J Surg 16:576-581; discussion 581-582.